Journal article icon

Journal article

Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes

Abstract:
Despite early clinical successes, the mechanisms of action of low-dose interleukin-2 (LD-IL-2) immunotherapy remain only partly understood. Here we examine the effects of interval administration of low-dose recombinant IL-2 (iLD-IL-2) in type 1 diabetes using high-resolution single-cell multiomics and flow cytometry on longitudinally-collected peripheral blood samples. Our results confirm that iLD-IL-2 selectively expands thymic-derived FOXP3+HELIOS+ regulatory T cells and CD56bright NK cells, and show that the treatment reduces the frequency of IL-21-producing CD4+ T cells and of two innate-like mucosal-associated invariant T and Vγ9Vδ2CD8+ T cell subsets. The cellular changes induced by iLD-IL-2 associate with an anti-inflammatory gene expression signature, which remains detectable in all T and NK cell subsets analysed one month after treatment. These findings warrant investigations into the potential longer-term clinical benefits of iLD-IL-2 in immunotherapy.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41467-022-34162-3

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Human Genetics Wt Centre
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
203141/Z/16/Z
More from this funder
Funder identifier:
https://ror.org/02swwpp84
Grant:
1-SRA-2019-657-A-N
More from this funder
Funder identifier:
https://ror.org/03ntprd85
Grant:
13/JTA (OCT2013/DR/1044)
More from this funder
Funder identifier:
https://ror.org/05m8dr349


Publisher:
Springer Nature
Journal:
Nature Communications More from this journal
Volume:
13
Article number:
7324
Publication date:
2022-11-28
Acceptance date:
2022-10-17
DOI:
EISSN:
2041-1723


Language:
English
Pubs id:
1285498
Local pid:
pubs:1285498
Deposit date:
2022-10-24
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP